|1|A novel oncolytic viral therapy and imaging technique for gastric cancer using a genetically engineered vaccinia virus carrying the human sodium iodide symporter. (24383569)
Jun K.H.... Fong Y.
|2|Effects of nasal or pulmonary delivered treatments with an adenovirus vectored interferon (mDEF201) on respiratory and systemic infections in mice caused by cowpox and vaccinia viruses. (23874722)
Smee D.F.... Turner J.D.
|3|Inactivation of vaccinia virus by natural sunlight and by artificial UVB radiation. (22816993)
Sagripanti J.L.... Lytle C.D.
|4|Viral antigen density and confinement time regulate the reactivity pattern of CD4 T-cell responses to vaccinia virus infection. (23248307)
Vanguri V.... Huseby E.S.
|5|Vaccinia virus protein N2 is a nuclear IRF3 inhibitor that promotes virulence. (23761407)
Ferguson B.J.... Smith G.L.
|6|Limited Effectiveness of Psoralen- and Ultraviolet-Inactivated Vaccinia Virus on SHIV Infection. (24130561)
|7|Primary human leukocyte subsets differentially express vaccinia virus receptors enriched in lipid rafts. (23785200)
Byrd D.... Yu Q.
|8|CD4+ T cells provide intermolecular help to generate robust antibody responses in vaccinia virus-vaccinated humans. (23667112)
Yin L.... Stern L.J.
|9|Inhibitors of C5 complement enhance vaccinia virus oncolysis. (23661042)
Magge D.... Bartlett D.L.
|10|A mechanism for induction of a hypoxic response by vaccinia virus. (23836663)
Mazzon M.... Smith G.L.
|11|Biogenesis of the vaccinia virus membrane: genetic and ultrastructural analysis of the contributions of the A14 and A17 proteins. (23135725)
Unger B.... Traktman P.
|12|Resistance to two heterologous neurotropic oncolytic viruses, Semliki Forest virus and vaccinia virus, in experimental glioma. (23221568)
VAohAo-Koskela M.J.... Bell J.C.
|13|Vaccinia virus A19 protein participates in the transformation of spherical immature particles to barrel-shaped infectious virions. (23885081)
Satheshkumar P.S.... Moss B.
|14|Evaluation of normalization strategies for qPCR quantitation of intracellular viral DNA: the example of Vaccinia virus. (22981457)
Poyot T.... Peinnequin A.
|15|Mutagenesis of the palmitoylation site in vaccinia virus envelope glycoprotein B5. (22238237)
Lorenzo M.M.... Blasco R.
|16|Susceptibility to vaccinia virus infection and spread in mice is determined by age at infection, allergen sensitization and mast cell status. (22286752)
Domenico J.... Gelfand E.W.
|17|Virotherapy of canine tumors with oncolytic vaccinia virus GLV-1h109 expressing an anti-VEGF single-chain antibody. (23091626)
Patil S.S.... Szalay A.A.
|18|Incorporation of the B18R gene of vaccinia virus into an oncolytic herpes simplex virus improves antitumor activity. (22692498)
Fu X.... Zhang X.
|19|Emergence and reemergence of vaccinia-like viruses: global scenario and perspectives. (23729995)
Singh R.K.... Hosamani M.
|20|Vaccinia and other viruses with available vaccines show marked homology with the HIV-1 envelope glycoprotein: the prospect of using existing vaccines to stem the AIDS pandemic. (21851326)
|21|Epitope mapping by random peptide phage display reveals essential residues for vaccinia extracellular enveloped virion spread. (23006741)
He Y.... Fisher R.W.
|22|Removal of vaccinia virus genes that block interferon type I and II pathways improves adaptive and memory responses of the HIV/AIDS vaccine candidate NYVAC-C in mice. (22419805)
GA^mez C.E.... Esteban M.
|23|A small molecule screen in yeast identifies inhibitors targeting protein-protein interactions within the vaccinia virus replication complex. (22884885)
Flusin O.... Iseni F.
|24|A vaccinia virus-driven interplay between the MKK4/7-JNK1/2 pathway and cytoskeleton reorganization. (22031940)
Pereira A.C.... Bonjardim C.A.
|25|Stunned silence: gene expression programs in human cells infected with monkeypox or vaccinia virus. (21267444)
Rubins K.H.... Brown P.O.
|26|Immunization with recombinant DNA and modified vaccinia virus Ankara (MVA) vectors delivering PSCA and STEAP1 antigens inhibits prostate cancer progression. (21182993)
Krupa M.... Esteban M.
|27|Stability of vaccinia-vectored recombinant oral rabies vaccine under field conditions: a 3-year study. (22468025)
Hermann J.R.... Gatewood D.M.
|28|MicroRNA regulation of glycoprotein B5R in oncolytic vaccinia virus reduces viral pathogenicity without impairing its antitumor efficacy. (21386827)
Hikichi M.... Nakamura T.
|29|Identification of protein-protein interaction inhibitors targeting vaccinia virus processivity factor for development of antiviral agents. (21844323)
Schormann N.... Chattopadhyay D.
|30|Development of Vaccinia reporter viruses for rapid, high content analysis of viral function at all stages of gene expression. (21569797)
Dower K.... Connor J.H.
|31|A kinesin-1 binding motif in vaccinia virus that is widespread throughout the human genome. (21915095)
Dodding M.P.... Way M.
|32|Evaluation of a modified vaccinia virus Ankara (MVA)-based candidate pandemic influenza A/H1N1 vaccine in the ferret model. (20719991)
Kreijtz J.H.... Rimmelzwaan G.F.
|33|Viral host-range factor C7 or K1 is essential for modified vaccinia virus Ankara late gene expression in human and murine cells, irrespective of their capacity to inhibit protein kinase R-mediated phosphorylation of eukaryotic translation initiation factor 2alpha. (19846675)
Backes S.... Sutter G.
|34|Insertion of vaccinia virus C7L host range gene into NYVAC-B genome potentiates immune responses against HIV-1 antigens. (20613977)
NA!jera J.L.... Esteban M.
|35|Macrophage inflammatory protein 3alpha deficiency in atopic dermatitis skin and role in innate immune response to vaccinia virus. (17141855)
Kim B.E.... Howell M.D.
|36|Immune responses to vaccinia and influenza elicited during primary versus recent or distant secondary smallpox vaccination of adults. (17014939)
Treanor J.... Topham D.J.
|37|Vaccinia virus activation of CCR5 invokes tyrosine phosphorylation signaling events that support virus replication. (16809330)
Rahbar R.... Fish E.N.
|38|Recombinant modified vaccinia Ankara primes functionally activated CTL specific for a melanoma tumor antigen epitope in melanoma patients with a high risk of disease recurrence. (15386406)
Smith C.L.... Cerundolo V.
|39|Phase I study of sequential vaccinations with fowlpox-CEA(6D)-TRICOM alone and sequentially with vaccinia-CEA(6D)-TRICOM, with and without granulocyte-macrophage colony-stimulating factor, in patients with carcinoembryonic antigen-expressing carcinomas. (15613691)
Marshall J.L.... Schlom J.
|40|Enhancement of vaccinia vaccine potency by linkage of tumor antigen gene to gene encoding calreticulin. (15364449)
Hsieh C.J.... Wu T.C.
|41|Regulation of interleukin 12 and interleukin 10 expression in vaccinia virus-infected human monocytes and U-937 cell line. (10880234)
Slezak K.... Rokita H.
|42|Redirected cellular cytotoxicity by infection of effector cells with a recombinant vaccinia virus encoding a tumor-specific monoclonal antibody. (10811480)
Paul S.... Kieny M.P.
|43|Vaccination with a recombinant vaccinia virus encoding a "self" antigen induces autoimmune vitiligo and tumor cell destruction in mice: requirement for CD4(+) T lymphocytes. (10077623)
Overwijk W.W.... Restifo N.P.
|44|Infection with a recombinant vaccinia virus encoding myelin proteolipid protein causes suppression of chronic relapsing-remitting experimental allergic encephalomyelitis. (10337913)
Wang L.Y.... Fujinami R.S.
|45|Gene transfer into human dendritic antigen-presenting cells by vaccinia virus and adenovirus vectors. (9917089)
Di Nicola M.... Gianni A.M.
|46|Induction of varicella-zoster virus-neutralizing antibodies in mice by co-infection with recombinant vaccinia viruses expressing the gH or gL gene. (8627224)
NA9meckovA! S.... KutinovA! L.
|47|Inhibition of human immunodeficiency virus type 1 and vaccinia virus infection by a dominant negative factor of the interferon regulatory factor family expressed in monocytic cells. (8552643)
Thornton A.M.... Ozato K.
|48|Assembly, intracellular localization, and nucleotide binding properties of the human peptide transporters TAP1 and TAP2 expressed by recombinant vaccinia viruses. (7673167)
Russ G.... Bennink J.R.
|49|Differential inhibitory effects of 5-bromodeoxyuridine on vaccinia and monkeypox viruses. (212474)
Yoshii T.... Kono R.
|50|Smallpox vaccinia with late interstitial keratitis; a case report. (13478034)
WOOD E.H.... SCHROEDER C.F.